pubmed.ncbi.nlm.nih.gov

Treatment of acute migraine attack: naproxen and placebo compared - PubMed

Clinical Trial

Treatment of acute migraine attack: naproxen and placebo compared

K Nestvold et al. Cephalalgia. 1985 Jun.

Abstract

A double-blind, cross-over, randomized study of acute migraine attack compared treatment results of naproxen with that of placebo. Each treatment period continued for either three months or six migraine attacks, whichever occurred first. The initial dose of naproxen was 750 mg, with additional 250-500 mg doses taken if and when required, to a maximum of five 250 mg tablets within a period of 24 h in each migraine attack. Forty-one patients were enrolled in the study; they had all experienced at least two but not more than eight migraine attacks a month during the preceding year. Thirty-two patients completed the two treatment periods. Naproxen was statistically significantly superior to placebo in reducing the severity of head pain, nausea, and photophobia; in shortening the duration of head pain, nausea, vomiting, photophobia, and lightheadedness; in diminishing the frequency of vomiting; and in decreasing the need for escape medication. Both patient and physician treatment preferences significantly favoured naproxen. Nine side effects were experienced by seven patients while receiving placebo and seven by five patients during naproxen treatment. Mild gastrointestinal discomfort was the main complaint. Only one patient withdrew from treatment because of a side effect, which occurred while receiving placebo.

PubMed Disclaimer

Cited by

The clinician's approach to the management of headache.
Maizels M. Maizels M. West J Med. 1998 Mar;168(3):203-12. West J Med. 1998. PMID: 9549429 Free PMC article. Review.
Treatment of acute migraine in the emergency department.
Gupta S, Oosthuizen R, Pulfrey S. Gupta S, et al. Can Fam Physician. 2014 Jan;60(1):47-9. Can Fam Physician. 2014. PMID: 24452560 Free PMC article. No abstract available.
Triptan-induced latent sensitization: a possible basis for medication overuse headache.
De Felice M, Ossipov MH, Wang R, Lai J, Chichorro J, Meng I, Dodick DW, Vanderah TW, Dussor G, Porreca F. De Felice M, et al. Ann Neurol. 2010 Mar;67(3):325-37. doi: 10.1002/ana.21897. Ann Neurol. 2010. PMID: 20373344 Free PMC article.
Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan.
Friedman BW, Solorzano C, Esses D, Xia S, Hochberg M, Dua N, Heins A, Sasso P, Bijur PE, Lipton RB, Gallagher EJ. Friedman BW, et al. Ann Emerg Med. 2010 Jul;56(1):7-17. doi: 10.1016/j.annemergmed.2010.02.005. Epub 2010 Mar 19. Ann Emerg Med. 2010. PMID: 20303198 Free PMC article. Clinical Trial.
Do non-steroidal anti-inflammatory agents have a role in the treatment of migraine headaches?
Diamond S, Freitag FG. Diamond S, et al. Drugs. 1989 Jun;37(6):755-60. doi: 10.2165/00003495-198937060-00001. Drugs. 1989. PMID: 2667935 Review. No abstract available.

Treatment of acute migraine attack: naproxen and placebo compared - PubMed